Cellular and Molecular Aspects of Goodpasture Syndrome

被引:0
|
作者
Alenzi, Faris Q. [1 ]
Salem, Mohamed L. [2 ]
Alenazi, Fawwaz A. [3 ]
Wyse, Richard K. [4 ]
机构
[1] Prince Salman Univ, Coll Appl Med Sci, Al Kharj, Saudi Arabia
[2] Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt
[3] King Fahad Med City, Dept Pediat, Riyadh, Saudi Arabia
[4] Univ London Imperial Coll Sci Technol & Med, Dept Surg, London, England
关键词
anti-glomerular basement membrane disease; autoantibodies; glomerulonephritis; major histocompatibility complex; BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; T-CELLS; PLASMA-EXCHANGE; ALPHA-3; CHAIN; ANTIBODY; DISEASE; AUTOANTIGEN; ANTIGEN; SEQUENCE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Goodpasture syndrome, a rare human autoimmune disorder, is characterized by the presence of pathogenic autoantibodies that react with the components of the glomerular basement membrane. The clinical condition of the Goodpasture syndrome is characterized by an acute necrotizing glomerulonephritis, often with accompanying pulmonary hemorrhage. Notably, the Goodpasture antigen has been localized to the noncollagenous domain of the alpha 3 chain of type IV collagen. Additionally, human leukocyte antigen-DR2, and to a lesser extent human leukocyte antigen-DR4, have been identified as important restriction elements. The role of T cells in Goodpasture syndrome is indicated by the highly restricted specificity of the antibody response and the strong major histocompatibility complex class II association. In this review article, we briefly describe the latest views on the molecular and cellular themes of Goodpasture syndrome.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] SYNDROME OF GOODPASTURE - THERAPEUTIC ASPECTS
    MORICHEAUBEAUCHANT, G
    PATTE, D
    PATTE, F
    TOUCHARD, G
    TALINDEYSAC, A
    NOLEN, P
    OUEST MEDICAL, 1977, 30 (19): : 1313 - 1317
  • [2] Pathogenesis of Goodpasture syndrome: A molecular perspective
    Borza, DB
    Neilson, EG
    Hudson, BG
    SEMINARS IN NEPHROLOGY, 2003, 23 (06) : 522 - 531
  • [3] GOODPASTURE-SYNDROME - MOLECULAR AND CLINICAL ADVANCES
    KELLY, PT
    HAPONIK, EF
    MEDICINE, 1994, 73 (04) : 171 - 185
  • [4] GOODPASTURE SYNDROME
    DUMINIET, H
    MACSEARRAIGH, E
    KIDNEY INTERNATIONAL, 1978, 13 (05) : 428 - 429
  • [5] GOODPASTURE SYNDROME
    GERMEAU, A
    JOURNAL BELGE DE RADIOLOGIE, 1977, 60 (03): : 310 - 310
  • [6] GOODPASTURE SYNDROME
    WAREMBOU, H
    DUPONT, A
    VASEUR, P
    BERTRAND, M
    LILLE MEDICAL, 1968, 13 (05): : 607 - &
  • [7] GOODPASTURE SYNDROME
    PROKOPCHUK, VS
    KALUGIN, VA
    TASHHUK, VK
    TERAPEVTICHESKII ARKHIV, 1984, 56 (03) : 131 - 134
  • [8] GOODPASTURE SYNDROME
    STEINER, B
    BRITISH MEDICAL JOURNAL, 1966, 1 (5482): : 292 - &
  • [9] Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects
    Antzelevitch, Charles
    Patocskai, Bence
    CURRENT PROBLEMS IN CARDIOLOGY, 2016, 41 (01) : 7 - 57
  • [10] GOODPASTURE SYNDROME
    STUMMVOL.HK
    PINGGERA, WF
    SINGER, F
    WOLF, A
    LEITHNER, C
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1974, 124 (04) : 54 - 54